An antibody from a patient with ranitidine-induced thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for drug- induced antibodies

Blood

Volumn 92, Issue 7, 1998, Pages 2359-2365

  Gentilini, G ^b   Curtis, B R ^b   Aster, R H ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ATENOLOL; DEXTROPROPOXYPHENE; DRUG ANTIBODY; GLYCOPROTEIN IB; MONOCLONAL ANTIBODY; PARACETAMOL; RANITIDINE;

AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG SENSITIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOPRECIPITATION; PRIORITY JOURNAL; STOMACH DISEASE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0032190417     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.7.2359.2359_2359_2365     Document Type: Article

References (33)

1. McCrae KR, Cines DB: Drug-induced thrombocytopenias, in Loscalzo J, Schaefer AI (eds): Thrombosis and Hemorrhage. New York, NY, Blackwell, 1994, p 545
2. George JN, El Harake M, Aster RH: Thrombocytopenia due to platelet destruction by immunologic mechanisms, in Beuter E, Lichtman MA, Coller BS, Kipps TJ (eds): Hematology, (ed 5) New York, NY, McGrawHill, 1995, p 1315
3. Aster RH: Response of thrombocytes to toxic injury, in Bloom JC (ed): Toxicology of the Hematopoietic System (vol 4), Comprehensive Toxicology. New York, NY, Elsevier, 1997, p 263
4. Berndt MC, Chong BH, Boll HA, Zola H, Castaldi PA: Molecular characterization of quinine/quinidine, drug-dependent antibody platelet interaction using monoclonal antibodies. Blood 66:1292, 1985
5. Visentin GP, Wolfmeyer K, Newman PJ, Aster RH: Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion 30:694, 1990
6. Curtis BR, McFarland JG, Wu GG, Visentin GP, Aster RH: Antibodies in sulfonamide-induced immune thrombocytopenia recognized calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. Blood 84:186, 1994
7. Mann HJ, Schneider JR, Miller JB, Delaney JP: Cimetidine- associated thrombocytopenia. Drug Intel Clin Pharm 17:126, 1983
8. Bajjoka AE: Ranitidine-induced thrombocytopenia. Arch Intern Med 151:203, 1991
9. Humphries JE: Thrombocytopenia associated with famotidine in a hemophilic. Ann Pharmacother 26:262, 1992
10. Hallberg T, Dohlsten M, Baldetorp B: Demonstration of histamine receptors on human platelets by flow cytometry. Scand J Haematol 32:113, 1984
11. 2 receptor antagonists. Agents Actions 18:115, 1986
12. Lopez JA, Li CQ, Weisman S, Chambers M: The glycoprotein Ib-IX complex-specific monoclonal antibody SZ1 binds to a confirmation-sensitive epitope on glycoprotein IX: Implications for the target antigen quinine/quinidine-dependent autoantibodies. Blood 85:1254, 1995
13. Visentin GP, Newman PJ, Aster RH: Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa. Blood 77:2668, 1991
14. Chaoyang LS, Martin E, Roth GJ: The genetic detect in two well studied cases of Bernard-Soulier syndrome: A point mutation in the fifth leucine-repeat of platelet glyco protein Ibα. Blood 86:3805, 1995
15. Grant SM, Langtry HD, Brogden RN: Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 37:801, 1989
16. Hill SJ: Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev 42:45, 1990
17. Chong BH, Du X, Berndt MC, Horn S, Chesterman CM: Characterization of the binding domains on platelet glycoproteins Ib/IX and IIb/IIIa complexes for the quinine/ quinidine-dependent antibodies. Blood 77:2190, 1991
18. 2 receptor biology. Am J Physiol 273:G987, 1997
19. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL: International Union of Pharmacology. XIII. Classification of histamine receptors. Pharm Rev 49:253, 1997
20. Collen MJ: Cimetidine-associated thrombocytopenia and leukopenia. West J Med 132:257, 1980
21. Spychal RT, Wickham NWR: Thrombocytopenia associated with ranitidine. BMJ 291:1687, 1985
22. Gibson PR, Pidcock ME: Immune-mediated thrombocytopenia associated with ranitidine therapy. Med J Aust 145:661, 1986
23. Pearson MW: Thrombocytopenia associated with ranitidine. BMJ 292:489, 1986
24. Gafter U, Zevin D, Komlos L, Livni E, Levi J: Thrombocytopenia associated with hypersensitivity to ranitidine: Possible cross- reactivity with cimetidine. Am J Gastroenerol 85:560, 1989
25. Oymak O, Akpolat T, Arik N, Yasavul U, Turgan C, Caglar S: Reversible neutropenia and thrombocytopenia during famotidine treatment. Ann Pharmacother 28:406, 1994
26. James C, Prout BJ: Marrow suppression and intravenous cimetidine. Lancet 1:987, 1978
27. Yue CP, Mann KS, Chan KH: Severe thrombocytopenia due to combined cimetidine and phenytoin therapy. Neurosurgery 20:963, 1987
28. 2 receptors and histadine D carboxylase in normal and leukemic human monocytes and macrophages. Am J Physiol 267:R602, 1994
29. 2 receptors in peripheral blood mononuclear cells. J Biol Chem 269:9952, 1994
30. Du X, Deutler L, Ruan C, Castaldi PA, Bemdt MC: Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane. Blood 60:1524, 1987
31. Clemetson KJ, Clemetson JM: Platelet GPIb-V-IX complex. Structure, function, physiology, and pathology. Semin Thromb Hemost 21:130, 1995
32. Lopez JA, Dong JF: Structure and function of the glycoprotein Ib-IX-V complex. Curr Opin Hematol 4:323, 1997
33. Christie DJ, Weber RW, Mullen PC, Cook JM, Aster RH: Structural features of the quinine and quinidine molecules necessary for the binding of drug-induced antibodies to the human platelets. J Lab Clin Med 104:730, 1984